Response to "Comments on whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)"
Radiother Oncol
.
2022 May:170:246.
doi: 10.1016/j.radonc.2022.02.037.
Epub 2022 Mar 10.
Authors
Govindaraj Ganesan
1
,
Sasipriya Ponniah
2
,
Vivek Sundaram
3
,
Praveen Kumar Marimuthu
2
,
Venkatraman Pitchaikannu
2
,
Manikandan Chandrasekaran
2
,
Janakiraman Thangarasu
4
,
Gunasekaran Kannupaiyan
2
,
Prabhu Ramamoorthy
2
,
Brindha Thangaraj
2
,
Harshavardhanan Sasipriya Govindaraj
2
,
Shree Vaishnavi Raguram
2
Affiliations
1
Harshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India. Electronic address: govindarajganesan@gmail.com.
2
Harshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
3
Sundaram Hospital, Trichy, India.
4
RPS Hospitals, Chennai, India.
PMID:
35283271
PMCID:
PMC8907107
DOI:
10.1016/j.radonc.2022.02.037
No abstract available
Publication types
Letter
Randomized Controlled Trial
Comment
MeSH terms
COVID-19*
Humans
Lung / radiation effects
Prospective Studies
SARS-CoV-2